Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited to Report First Quarter Fiscal 2015 Financial Results and Host Conference Call View HTML
Toggle Summary Technical Feasibility Established for MosaiQ(TM) CMV and Syphilis Disease Screening Assays
Preliminary Study Data Meets Goals for Concordance
View HTML
Toggle Summary Quotient Limited Reports Fourth Quarter and Full-Year Financial Results for the Year Ended March 31, 2014 View HTML
Toggle Summary Quotient Limited to Present at the UBS Global Healthcare Conference View HTML
Toggle Summary Quotient Limited To Report Fourth Quarter and Fiscal Year 2014 Financial Results and Host Conference Call View HTML
Toggle Summary Quotient Limited Prices Initial Public Offering View HTML
Toggle Summary Evaluation of the MosaiQ™ Platform Chosen as a Top Poster at the AABB 2013 Annual Meeting View HTML
Toggle Summary Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners View HTML
Toggle Summary Quotient Biodiagnostics Signs 36 Month Laboratory Solutions Agreement With Amerinet Inc. to Supply Blood Bank Reagents to Member Hospitals View HTML
Toggle Summary Quotient Receives FDA License to Sell a Range of Rare Polyclonal Antisera Products in the USA View HTML